This inventor holds 2 USPTO granted patents. Top assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo. Active years: 1990-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1991
Title: The Innovative Contributions of Tyoku Matsuhashi
Introduction
Tyoku Matsuhashi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of allergen research, particularly in developing hyposensitization agents for cedar pollen allergies. With a total of 2 patents, Matsuhashi's work is paving the way for advancements in allergy treatment.
Latest Patents
Matsuhashi's latest patents focus on novel hyposensitization agents. The first patent describes a hyposensitization agent prepared by covalently attaching a saccharide to a cedar pollen allergen. This agent significantly accelerates the production of immunoglobulin G and M antibodies while drastically reducing the production of immunoglobulin E antibodies, which are responsible for allergic reactions. This innovation allows for administration to cedar pollinosis patients without the risk of anaphylaxis, effectively shortening the hyposensitization period to about 1/3 to 1/200 of the traditional time.
The second patent also involves a hyposensitization agent created by attaching various saccharides to a cedar pollen allergen. This agent enhances the production of immunoglobulin G and M antibodies while minimizing the risk of eliciting anaphylaxis and allergy. The advancements in these patents represent a significant leap forward in allergy treatment methodologies.
Career Highlights
Matsuhashi is associated with Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, where he continues to innovate in the field of allergen research. His work has garnered attention for its potential to improve the quality of life for individuals suffering from cedar pollen allergies.
Collaborations
Matsuhashi collaborates with notable colleagues, including Mitsuko Usui and Masakazu Mitsuhashi. Their combined efforts contribute to the ongoing research and development of effective allergy treatments.
Conclusion
Tyoku Matsuhashi's innovative work in developing hyposensitization agents marks a significant advancement in allergy treatment. His contributions are vital for improving patient outcomes and reducing the risks associated with cedar pollen allergies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile